 | • レポートコード：MRC2Q12-00769 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、AAVプラスミドの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にAAVプラスミドのグローバル市場のxxx％を占める「C末端TGFPタグ型AAVプラスミド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「研究所」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 AAVプラスミドの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのAAVプラスミド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 AAVプラスミドのグローバル主要プレイヤーには、PlasmidFactory GmbH、GeneCopoeia、Thermo Fisher Scientific、OriGene、Takara Bio、Azenta Life Sciences、Sartorius、Aldevron、Omega Bio Tek、Addgene、Viral Vector Core、Azenta、OXGENEなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 AAVプラスミド市場は、種類と用途によって区分されます。世界のAAVプラスミド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 C末端TGFPタグ型AAVプラスミド、C末端TRFPタグ型AAVプラスミド 【用途別セグメント】 研究所、病院、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - AAVプラスミド製品概要 - 種類別市場（C末端TGFPタグ型AAVプラスミド、C末端TRFPタグ型AAVプラスミド） - 用途別市場（研究所、病院、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のAAVプラスミド販売量予測2017-2028 - 世界のAAVプラスミド売上予測2017-2028 - AAVプラスミドの地域別販売量 - AAVプラスミドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別AAVプラスミド販売量 - 主要メーカー別AAVプラスミド売上 - 主要メーカー別AAVプラスミド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（C末端TGFPタグ型AAVプラスミド、C末端TRFPタグ型AAVプラスミド） - AAVプラスミドの種類別販売量 - AAVプラスミドの種類別売上 - AAVプラスミドの種類別価格 ・用途別市場規模（研究所、病院、その他） - AAVプラスミドの用途別販売量 - AAVプラスミドの用途別売上 - AAVプラスミドの用途別価格 ・北米市場 - 北米のAAVプラスミド市場規模（種類別、用途別） - 主要国別のAAVプラスミド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのAAVプラスミド市場規模（種類別、用途別） - 主要国別のAAVプラスミド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のAAVプラスミド市場規模（種類別、用途別） - 主要国別のAAVプラスミド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のAAVプラスミド市場規模（種類別、用途別） - 主要国別のAAVプラスミド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのAAVプラスミド市場規模（種類別、用途別） - 主要国別のAAVプラスミド市場規模（トルコ、サウジアラビア） ・企業情報 PlasmidFactory GmbH、GeneCopoeia、Thermo Fisher Scientific、OriGene、Takara Bio、Azenta Life Sciences、Sartorius、Aldevron、Omega Bio Tek、Addgene、Viral Vector Core、Azenta、OXGENE ・産業チェーン及び販売チャネル分析 - AAVプラスミドの産業チェーン分析 - AAVプラスミドの原材料 - AAVプラスミドの生産プロセス - AAVプラスミドの販売及びマーケティング - AAVプラスミドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - AAVプラスミドの産業動向 - AAVプラスミドのマーケットドライバー - AAVプラスミドの課題 - AAVプラスミドの阻害要因 ・主な調査結果 |
AAV plasmids (adeno-associated virus plasmids) are the primary viral vectors used in in vivo gene therapy clinical trials due to their high efficiency and enhanced safety in humans.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for AAV Plasmid estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for AAV Plasmid is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for AAV Plasmid is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for AAV Plasmid is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of AAV Plasmid include PlasmidFactory GmbH, GeneCopoeia, Thermo Fisher Scientific, OriGene, Takara Bio, Azenta Life Sciences, Sartorius, Aldevron and Omega Bio Tek, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the AAV Plasmid companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional AAV Plasmid market. Further, it explains the major drivers and regional dynamics of the global AAV Plasmid market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
PlasmidFactory GmbH
GeneCopoeia
Thermo Fisher Scientific
OriGene
Takara Bio
Azenta Life Sciences
Sartorius
Aldevron
Omega Bio Tek
Addgene
Viral Vector Core
Azenta
OXGENE
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
AAV Plasmid Segment by Type
AAV Plasmids with C-terminal TGFP Tag
AAV Plasmid with C-terminal TRFP Tag
AAV Plasmid Segment by Application
Laboratory
Hospital
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the AAV Plasmid market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for AAV Plasmid market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of AAV Plasmid, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for AAV Plasmid, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AAV Plasmid revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global AAV Plasmid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for AAV Plasmid revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including PlasmidFactory GmbH, GeneCopoeia, Thermo Fisher Scientific, OriGene, Takara Bio, Azenta Life Sciences, Sartorius, Aldevron and Omega Bio Tek, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of AAV Plasmid in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AAV Plasmid companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AAV Plasmid revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AAV Plasmid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AAV Plasmids with C-terminal TGFP Tag
1.2.3 AAV Plasmid with C-terminal TRFP Tag
1.3 Market by Application
1.3.1 Global AAV Plasmid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global AAV Plasmid Market Perspective (2017-2028)
2.2 AAV Plasmid Growth Trends by Region
2.2.1 AAV Plasmid Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 AAV Plasmid Historic Market Size by Region (2017-2022)
2.2.3 AAV Plasmid Forecasted Market Size by Region (2023-2028)
2.3 AAV Plasmid Market Dynamics
2.3.1 AAV Plasmid Industry Trends
2.3.2 AAV Plasmid Market Drivers
2.3.3 AAV Plasmid Market Challenges
2.3.4 AAV Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AAV Plasmid Players by Revenue
3.1.1 Global Top AAV Plasmid Players by Revenue (2017-2022)
3.1.2 Global AAV Plasmid Revenue Market Share by Players (2017-2022)
3.2 Global AAV Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AAV Plasmid Revenue
3.4 Global AAV Plasmid Market Concentration Ratio
3.4.1 Global AAV Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AAV Plasmid Revenue in 2021
3.5 AAV Plasmid Key Players Head office and Area Served
3.6 Key Players AAV Plasmid Product Solution and Service
3.7 Date of Enter into AAV Plasmid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AAV Plasmid Breakdown Data by Type
4.1 Global AAV Plasmid Historic Market Size by Type (2017-2022)
4.2 Global AAV Plasmid Forecasted Market Size by Type (2023-2028)
5 AAV Plasmid Breakdown Data by Application
5.1 Global AAV Plasmid Historic Market Size by Application (2017-2022)
5.2 Global AAV Plasmid Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America AAV Plasmid Market Size (2017-2028)
6.2 North America AAV Plasmid Market Size by Type
6.2.1 North America AAV Plasmid Market Size by Type (2017-2022)
6.2.2 North America AAV Plasmid Market Size by Type (2023-2028)
6.2.3 North America AAV Plasmid Market Share by Type (2017-2028)
6.3 North America AAV Plasmid Market Size by Application
6.3.1 North America AAV Plasmid Market Size by Application (2017-2022)
6.3.2 North America AAV Plasmid Market Size by Application (2023-2028)
6.3.3 North America AAV Plasmid Market Share by Application (2017-2028)
6.4 North America AAV Plasmid Market Size by Country
6.4.1 North America AAV Plasmid Market Size by Country (2017-2022)
6.4.2 North America AAV Plasmid Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe AAV Plasmid Market Size (2017-2028)
7.2 Europe AAV Plasmid Market Size by Type
7.2.1 Europe AAV Plasmid Market Size by Type (2017-2022)
7.2.2 Europe AAV Plasmid Market Size by Type (2023-2028)
7.2.3 Europe AAV Plasmid Market Share by Type (2017-2028)
7.3 Europe AAV Plasmid Market Size by Application
7.3.1 Europe AAV Plasmid Market Size by Application (2017-2022)
7.3.2 Europe AAV Plasmid Market Size by Application (2023-2028)
7.3.3 Europe AAV Plasmid Market Share by Application (2017-2028)
7.4 Europe AAV Plasmid Market Size by Country
7.4.1 Europe AAV Plasmid Market Size by Country (2017-2022)
7.4.2 Europe AAV Plasmid Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AAV Plasmid Market Size (2017-2028)
8.2 Asia-Pacific AAV Plasmid Market Size by Type
8.2.1 Asia-Pacific AAV Plasmid Market Size by Type (2017-2022)
8.2.2 Asia-Pacific AAV Plasmid Market Size by Type (2023-2028)
8.2.3 Asia-Pacific AAV Plasmid Market Share by Type (2017-2028)
8.3 Asia-Pacific AAV Plasmid Market Size by Application
8.3.1 Asia-Pacific AAV Plasmid Market Size by Application (2017-2022)
8.3.2 Asia-Pacific AAV Plasmid Market Size by Application (2023-2028)
8.3.3 Asia-Pacific AAV Plasmid Market Share by Application (2017-2028)
8.4 Asia-Pacific AAV Plasmid Market Size by Region
8.4.1 Asia-Pacific AAV Plasmid Market Size by Region (2017-2022)
8.4.2 Asia-Pacific AAV Plasmid Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America AAV Plasmid Market Size (2017-2028)
9.2 Latin America AAV Plasmid Market Size by Type
9.2.1 Latin America AAV Plasmid Market Size by Type (2017-2022)
9.2.2 Latin America AAV Plasmid Market Size by Type (2023-2028)
9.2.3 Latin America AAV Plasmid Market Share by Type (2017-2028)
9.3 Latin America AAV Plasmid Market Size by Application
9.3.1 Latin America AAV Plasmid Market Size by Application (2017-2022)
9.3.2 Latin America AAV Plasmid Market Size by Application (2023-2028)
9.3.3 Latin America AAV Plasmid Market Share by Application (2017-2028)
9.4 Latin America AAV Plasmid Market Size by Country
9.4.1 Latin America AAV Plasmid Market Size by Country (2017-2022)
9.4.2 Latin America AAV Plasmid Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AAV Plasmid Market Size (2017-2028)
10.2 Middle East & Africa AAV Plasmid Market Size by Type
10.2.1 Middle East & Africa AAV Plasmid Market Size by Type (2017-2022)
10.2.2 Middle East & Africa AAV Plasmid Market Size by Type (2023-2028)
10.2.3 Middle East & Africa AAV Plasmid Market Share by Type (2017-2028)
10.3 Middle East & Africa AAV Plasmid Market Size by Application
10.3.1 Middle East & Africa AAV Plasmid Market Size by Application (2017-2022)
10.3.2 Middle East & Africa AAV Plasmid Market Size by Application (2023-2028)
10.3.3 Middle East & Africa AAV Plasmid Market Share by Application (2017-2028)
10.4 Middle East & Africa AAV Plasmid Market Size by Country
10.4.1 Middle East & Africa AAV Plasmid Market Size by Country (2017-2022)
10.4.2 Middle East & Africa AAV Plasmid Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 PlasmidFactory GmbH
11.1.1 PlasmidFactory GmbH Company Details
11.1.2 PlasmidFactory GmbH Business Overview
11.1.3 PlasmidFactory GmbH AAV Plasmid Introduction
11.1.4 PlasmidFactory GmbH Revenue in AAV Plasmid Business (2017-2022)
11.1.5 PlasmidFactory GmbH Recent Developments
11.2 GeneCopoeia
11.2.1 GeneCopoeia Company Details
11.2.2 GeneCopoeia Business Overview
11.2.3 GeneCopoeia AAV Plasmid Introduction
11.2.4 GeneCopoeia Revenue in AAV Plasmid Business (2017-2022)
11.2.5 GeneCopoeia Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific AAV Plasmid Introduction
11.3.4 Thermo Fisher Scientific Revenue in AAV Plasmid Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 OriGene
11.4.1 OriGene Company Details
11.4.2 OriGene Business Overview
11.4.3 OriGene AAV Plasmid Introduction
11.4.4 OriGene Revenue in AAV Plasmid Business (2017-2022)
11.4.5 OriGene Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio AAV Plasmid Introduction
11.5.4 Takara Bio Revenue in AAV Plasmid Business (2017-2022)
11.5.5 Takara Bio Recent Developments
11.6 Azenta Life Sciences
11.6.1 Azenta Life Sciences Company Details
11.6.2 Azenta Life Sciences Business Overview
11.6.3 Azenta Life Sciences AAV Plasmid Introduction
11.6.4 Azenta Life Sciences Revenue in AAV Plasmid Business (2017-2022)
11.6.5 Azenta Life Sciences Recent Developments
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius AAV Plasmid Introduction
11.7.4 Sartorius Revenue in AAV Plasmid Business (2017-2022)
11.7.5 Sartorius Recent Developments
11.8 Aldevron
11.8.1 Aldevron Company Details
11.8.2 Aldevron Business Overview
11.8.3 Aldevron AAV Plasmid Introduction
11.8.4 Aldevron Revenue in AAV Plasmid Business (2017-2022)
11.8.5 Aldevron Recent Developments
11.9 Omega Bio Tek
11.9.1 Omega Bio Tek Company Details
11.9.2 Omega Bio Tek Business Overview
11.9.3 Omega Bio Tek AAV Plasmid Introduction
11.9.4 Omega Bio Tek Revenue in AAV Plasmid Business (2017-2022)
11.9.5 Omega Bio Tek Recent Developments
11.10 Addgene
11.10.1 Addgene Company Details
11.10.2 Addgene Business Overview
11.10.3 Addgene AAV Plasmid Introduction
11.10.4 Addgene Revenue in AAV Plasmid Business (2017-2022)
11.10.5 Addgene Recent Developments
11.11 Viral Vector Core
11.11.1 Viral Vector Core Company Details
11.11.2 Viral Vector Core Business Overview
11.11.3 Viral Vector Core AAV Plasmid Introduction
11.11.4 Viral Vector Core Revenue in AAV Plasmid Business (2017-2022)
11.11.5 Viral Vector Core Recent Developments
11.12 Azenta
11.12.1 Azenta Company Details
11.12.2 Azenta Business Overview
11.12.3 Azenta AAV Plasmid Introduction
11.12.4 Azenta Revenue in AAV Plasmid Business (2017-2022)
11.12.5 Azenta Recent Developments
11.13 OXGENE
11.13.1 OXGENE Company Details
11.13.2 OXGENE Business Overview
11.13.3 OXGENE AAV Plasmid Introduction
11.13.4 OXGENE Revenue in AAV Plasmid Business (2017-2022)
11.13.5 OXGENE Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global AAV Plasmid Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of AAV Plasmids with C-terminal TGFP Tag
Table 3. Key Players of AAV Plasmid with C-terminal TRFP Tag
Table 4. Global AAV Plasmid Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global AAV Plasmid Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global AAV Plasmid Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global AAV Plasmid Market Share by Region (2017-2022)
Table 8. Global AAV Plasmid Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global AAV Plasmid Market Share by Region (2023-2028)
Table 10. AAV Plasmid Market Trends
Table 11. AAV Plasmid Market Drivers
Table 12. AAV Plasmid Market Challenges
Table 13. AAV Plasmid Market Restraints
Table 14. Global AAV Plasmid Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global AAV Plasmid Revenue Share by Players (2017-2022)
Table 16. Global Top AAV Plasmid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Plasmid as of 2021)
Table 17. Ranking of Global Top AAV Plasmid Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by AAV Plasmid Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players AAV Plasmid Product Solution and Service
Table 21. Date of Enter into AAV Plasmid Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global AAV Plasmid Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global AAV Plasmid Revenue Market Share by Type (2017-2022)
Table 25. Global AAV Plasmid Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global AAV Plasmid Revenue Market Share by Type (2023-2028)
Table 27. Global AAV Plasmid Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global AAV Plasmid Revenue Share by Application (2017-2022)
Table 29. Global AAV Plasmid Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global AAV Plasmid Revenue Share by Application (2023-2028)
Table 31. North America AAV Plasmid Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America AAV Plasmid Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America AAV Plasmid Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America AAV Plasmid Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America AAV Plasmid Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America AAV Plasmid Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe AAV Plasmid Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe AAV Plasmid Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe AAV Plasmid Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe AAV Plasmid Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe AAV Plasmid Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe AAV Plasmid Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific AAV Plasmid Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific AAV Plasmid Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific AAV Plasmid Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific AAV Plasmid Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific AAV Plasmid Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific AAV Plasmid Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America AAV Plasmid Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America AAV Plasmid Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America AAV Plasmid Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America AAV Plasmid Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America AAV Plasmid Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America AAV Plasmid Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa AAV Plasmid Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa AAV Plasmid Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa AAV Plasmid Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa AAV Plasmid Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa AAV Plasmid Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa AAV Plasmid Market Size by Country (2023-2028) & (US$ Million)
Table 61. PlasmidFactory GmbH Company Details
Table 62. PlasmidFactory GmbH Business Overview
Table 63. PlasmidFactory GmbH AAV Plasmid Product
Table 64. PlasmidFactory GmbH Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 65. PlasmidFactory GmbH Recent Developments
Table 66. GeneCopoeia Company Details
Table 67. GeneCopoeia Business Overview
Table 68. GeneCopoeia AAV Plasmid Product
Table 69. GeneCopoeia Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 70. GeneCopoeia Recent Developments
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific AAV Plasmid Product
Table 74. Thermo Fisher Scientific Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Developments
Table 76. OriGene Company Details
Table 77. OriGene Business Overview
Table 78. OriGene AAV Plasmid Product
Table 79. OriGene Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 80. OriGene Recent Developments
Table 81. Takara Bio Company Details
Table 82. Takara Bio Business Overview
Table 83. Takara Bio AAV Plasmid Product
Table 84. Takara Bio Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 85. Takara Bio Recent Developments
Table 86. Azenta Life Sciences Company Details
Table 87. Azenta Life Sciences Business Overview
Table 88. Azenta Life Sciences AAV Plasmid Product
Table 89. Azenta Life Sciences Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 90. Azenta Life Sciences Recent Developments
Table 91. Sartorius Company Details
Table 92. Sartorius Business Overview
Table 93. Sartorius AAV Plasmid Product
Table 94. Sartorius Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 95. Sartorius Recent Developments
Table 96. Aldevron Company Details
Table 97. Aldevron Business Overview
Table 98. Aldevron AAV Plasmid Product
Table 99. Aldevron Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 100. Aldevron Recent Developments
Table 101. Omega Bio Tek Company Details
Table 102. Omega Bio Tek Business Overview
Table 103. Omega Bio Tek AAV Plasmid Product
Table 104. Omega Bio Tek Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 105. Omega Bio Tek Recent Developments
Table 106. Addgene Company Details
Table 107. Addgene Business Overview
Table 108. Addgene AAV Plasmid Product
Table 109. Addgene Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 110. Addgene Recent Developments
Table 111. Viral Vector Core Company Details
Table 112. Viral Vector Core Business Overview
Table 113. Viral Vector Core AAV Plasmid Product
Table 114. Viral Vector Core Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 115. Viral Vector Core Recent Developments
Table 116. Azenta Company Details
Table 117. Azenta Business Overview
Table 118. Azenta AAV Plasmid Product
Table 119. Azenta Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 120. Azenta Recent Developments
Table 121. OXGENE Company Details
Table 122. OXGENE Business Overview
Table 123. OXGENE AAV Plasmid Product
Table 124. OXGENE Revenue in AAV Plasmid Business (2017-2022) & (US$ Million)
Table 125. OXGENE Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AAV Plasmid Market Share by Type: 2021 VS 2028
Figure 2. AAV Plasmids with C-terminal TGFP Tag Features
Figure 3. AAV Plasmid with C-terminal TRFP Tag Features
Figure 4. Global AAV Plasmid Market Share by Application: 2021 VS 2028
Figure 5. Laboratory Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. AAV Plasmid Report Years Considered
Figure 9. Global AAV Plasmid Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global AAV Plasmid Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global AAV Plasmid Market Share by Region: 2021 VS 2028
Figure 12. Global AAV Plasmid Market Share by Players in 2021
Figure 13. Global Top AAV Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Plasmid as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by AAV Plasmid Revenue in 2021
Figure 15. North America AAV Plasmid Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America AAV Plasmid Market Size Market Share by Type (2017-2028)
Figure 17. North America AAV Plasmid Market Size Market Share by Application (2017-2028)
Figure 18. North America AAV Plasmid Market Size Share by Country (2017-2028)
Figure 19. United States AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe AAV Plasmid Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe AAV Plasmid Market Size Market Share by Type (2017-2028)
Figure 23. Europe AAV Plasmid Market Size Market Share by Application (2017-2028)
Figure 24. Europe AAV Plasmid Market Size Share by Country (2017-2028)
Figure 25. Germany AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific AAV Plasmid Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific AAV Plasmid Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific AAV Plasmid Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific AAV Plasmid Market Size Share by Region (2017-2028)
Figure 35. China AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America AAV Plasmid Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America AAV Plasmid Market Size Market Share by Type (2017-2028)
Figure 43. Latin America AAV Plasmid Market Size Market Share by Application (2017-2028)
Figure 44. Latin America AAV Plasmid Market Size Share by Country (2017-2028)
Figure 45. Mexico AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa AAV Plasmid Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa AAV Plasmid Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa AAV Plasmid Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa AAV Plasmid Market Size Share by Country (2017-2028)
Figure 51. Turkey AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE AAV Plasmid Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. PlasmidFactory GmbH Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 55. GeneCopoeia Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 57. OriGene Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 58. Takara Bio Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 59. Azenta Life Sciences Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 60. Sartorius Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 61. Aldevron Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 62. Omega Bio Tek Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 63. Addgene Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 64. Viral Vector Core Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 65. Azenta Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 66. OXGENE Revenue Growth Rate in AAV Plasmid Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed